We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
-7.33%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$465M
AUM Growth
-$46.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXEL icon
1
Exelixis
EXEL
$13.9B
$283M 60.81%
15,966,038
ESPR
2
DELISTED
Esperion Therapeutics
ESPR
$117M 25.08%
2,629,835
ALKS icon
3
Alkermes
ALKS
$8.82B
$43.7M 9.4%
1,030,639
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$9.64M 2.07%
400,000
INDA icon
5
iShares MSCI India ETF
INDA
$6.71B
$9.42M 2.02%
290,000
CLDX icon
6
Celldex Therapeutics
CLDX
$2.77B
$2.85M 0.61%
420,847

Similar funds

Meditor Group's Q3 2018 Portfolio in Review

As of Q3 2018, Meditor Group held 6 positions worth $465M, down 9.1% from $512M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 0%. Meditor Group opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier.

  • Meditor Group's ten largest holdings make up 100% of its $465M portfolio in Q3 2018.
  • Meditor Group opened 0 new positions and closed 0 in Q3 2018.
  • Meditor Group's portfolio value fell 9.1% quarter-over-quarter to $465M.

Based on Meditor Group's 13F filing for Q3 2018, filed 9 Oct 2018.